Delivery Order SPE2DX22D0029-SPE2D826F08TP

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract valued at $11,562.36 from the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This contract, designated as a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, represents a child award under a larger indefinite delivery contract vehicle. The contract carries no set-aside designation, indicating it was competitively awarded through open competition. The award supports federal medical procurement needs, particularly for military and veteran healthcare systems, and is part of AmerisourceBergen's extensive portfolio of pharmaceutical product deliveries.

This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports critical military healthcare programs worldwide, with customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor within the Defense Logistics Agency's pharmaceutical procurement strategy.